Reporting season 1HY25 is over … time to take stock!
Marc Kennis, February 28, 2025
Reporting season is over…time to take stock
Stuart Roberts from Stocks Down Under shares insights on market trends on Ausbiz. He notes strong performances from BlueScope (ASX:BSL), Worley (ASX:WOR) and A2 Milk (ASX:A2M), citing potential interest rate cuts that could benefit alternative financial stocks. Stuart highlights the resurgence of the energy sector and suggests investors focus on oil, gas and related industries.
Stuart discusses Whitehaven Coal (ASX:WHC), noting significant drops in coal prices but ongoing strong performance. Despite past supply constraints, Australian producers continue to deliver high-calorific coal. He points out that thermal coal markets may face a deficit by 2027, presenting opportunities for companies like Whitehaven Coal.
In life sciences this reporting season, Stuart mentions Island Pharmaceuticals (ASX:ILA) and its promising work on drugs for bioterrorism threats, such as dengue and Ebola. He sees 2023 as a pivotal year for data in life sciences, with many firms reaching key trial phases. Stuart suggests paying attention to unique, pre-revenue opportunities in life sciences.
Watch the entire interview here!
What are the Best ASX Stocks to invest in right now?
Check our ASX stock buy/sell tips
Blog Categories
Get Our Top 5 ASX Stocks for FY26
Recent Posts
Qantas (ASX:QAN) Soars 9% on FY25 Results as Revenue Hits A$23.8 Billion
Investors Reward Qantas as Recovery Turns Into Renewed Momentum Qantas (ASX:QAN) surged 9 percent today after unveiling its FY25 results,…
Why Telix (ASX:TLX) Fell 20% After FDA News – And What Investors Should Know
When expectations fall short, sentiment can shift in an instant. That is exactly what happened with Telix Pharmaceuticals (ASX: TLX)…
Inside Weebit Nano’s 333% Revenue Surge and the Future of ReRAM
Is This the Inflection Point Investors Have Been Waiting For? Weebit Nano (ASX:WBT) opened this morning with a 6% gain,…